November 8th , 2019, Shanghai Kindly Medical Instruments Co., Ltd. (“Company”) successfully listed on Hong Kong stock exchange main board(stock code: 1501, stock abbreviation: KDL MEDICAL). Company is a leading Chinese cardiovascular interventional device manufacturer. Company’s major products are primarily used for cardiovascular surgeries, and Company's products and R&D pipeline cover the four fields of cardiovascular intervention, neurological intervention, peripheral intervention and orthopedic intervention. According to Frost & Sullivan, Company ranked first in the PRC PCI supporting device market among domestic brands, in terms of sales revenue in 2018.
Company issued 40 million new shares in the global offering and was priced at HK$20.80 per share, with total proceeds being HK$832 million (assuming Over-Allotment is not exercised). The Hong Kong public offering subscription ratio is nearly 270 times.